Works matching AU Gordon, Michael S.


Results: 104
    1
    2

    Simulation and new learning technologies.

    Published in:
    Medical Teacher, 2001, v. 23, n. 1, p. 16, doi. 10.1080/01421590020007324
    By:
    • Issenberg, S. Barry;
    • Gordon, Michael S.;
    • Gordon, David Lee;
    • Safford, Robert E.;
    • Hart, Ian R.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

    Published in:
    2018
    By:
    • Goss, Glenwood D.;
    • Vokes, Everett E.;
    • Gordon, Michael S.;
    • Gandhi, Leena;
    • Papadopoulos, Kyriakos P.;
    • Rasco, Drew W.;
    • Fischer, JuDee S.;
    • Chu, Katharine L.;
    • Ames, William W.;
    • Mittapalli, Rajendar K.;
    • Lee, Ho‐Jin;
    • Zeng, Jiewei;
    • Roberts‐Rapp, Lisa A.;
    • Loberg, Lise I.;
    • Ansell, Peter J.;
    • Reilly, Edward B.;
    • Ocampo, Christopher J.;
    • Holen, Kyle D.;
    • Tolcher, Anthony W.;
    • Lee, Ho-Jin
    Publication type:
    journal article
    19
    20
    21
    22
    23
    24
    25

    Skill Improvement During Emergency Response to Terrorism Training.

    Published in:
    Prehospital Emergency Care, 2006, v. 10, n. 4, p. 507, doi. 10.1080/10903120600887072
    By:
    • Scott, Joseph A.;
    • Miller, Geoffrey T.;
    • Barry Issenberg, S.;
    • Brotons, Angel A.;
    • Gordon, David Lee;
    • Gordon, Michael S.;
    • McGaghie, William C.;
    • Petrusa, Emil R.
    Publication type:
    Article
    26
    27
    28
    29

    Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.

    Published in:
    Journal of Empirical Research on Human Research Ethics, 2018, v. 13, n. 2, p. 160, doi. 10.1177/1556264618755243
    By:
    • Chen, Donna T.;
    • Ko, Tomohiro M.;
    • Allen, Ashleigh A.;
    • Bonnie, Richard J.;
    • Suratt, Colleen E.;
    • Appelbaum, Paul S.;
    • Nunes, Edward V.;
    • Friedmann, Peter D.;
    • Lee, Joshua D.;
    • Gordon, Michael S.;
    • McDonald, Ryan;
    • Wilson, Donna;
    • Boney, Tamara Y.;
    • Murphy, Sean M.;
    • O’Brien, Charles P.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib.

    Published in:
    Journal of Clinical Pharmacology, 2015, v. 55, n. 4, p. 392, doi. 10.1002/jcph.437
    By:
    • Suttle, A. Benjamin;
    • Grossmann, Kenneth F.;
    • Ouellet, Daniele;
    • Richards‐Peterson, Lauren E.;
    • Aktan, Gursel;
    • Gordon, Michael S.;
    • LoRusso, Patricia M.;
    • Infante, Jeffrey R.;
    • Sharma, Sunil;
    • Kendra, Kari;
    • Patel, Manish;
    • Pant, Shubham;
    • Arkenau, Hendrik‐Tobias;
    • Middleton, Mark R.;
    • Blackman, Samuel C.;
    • Botbyl, Jeff;
    • Carson, Stanley W.
    Publication type:
    Article
    39

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    40

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    41

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    42

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    43

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    44

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    45

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    46

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    47

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    48

    Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    49

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article
    50

    CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
    By:
    • Farwell, Michael D.;
    • Gamache, Raymond F.;
    • Babazada, Hasan;
    • Hellmann, Matthew D.;
    • Harding, James J.;
    • Korn, Ron;
    • Mascioni, Alessandro;
    • Le, William;
    • Wilson, Ian;
    • Gordon, Michael S.;
    • Wu, Anna M.;
    • Ulaner, Gary A.;
    • Wolchok, Jedd D.;
    • Postow, Michael A.;
    • Pandit-Taskar, Neeta
    Publication type:
    Article